Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Achaogen Inc (AKAO)

Achaogen Inc (AKAO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cipla USA Furthers AMR Stewardship With Acquisition of Key Anti-infective ZEMDRI(TM) (IV Plazomicin)

Cipla USA Inc. ("Cipla USA"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla"), announced the acquisition...

AKAO : 0.11 (unch)
Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets

Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today it has reached...

AKAO : 0.11 (unch)
Achaogen (AKAO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Achaogen (AKAO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKAO : 0.11 (unch)
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%

Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement.

ESALY : 51.0000 (-1.05%)
AKAO : 0.11 (unch)
ASRT : 1.52 (-0.65%)
BSTC : 57.61 (-1.54%)
Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today...

AKAO : 0.11 (unch)
New Research Coverage Highlights Hewlett Packard Enterprise, Sunstone Hotel Investors, NTN Buzztime, Seadrill Partners, Achaogen, and China Automotive -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Hewlett Packard Enterprise Company...

SDLP : 1.74 (-0.58%)
AKAO : 0.11 (unch)
NTN : 2.96 (-0.54%)
SHO : 13.17 (+0.23%)
HPE : 13.25 (+1.38%)
CAAS : 1.92 (+2.67%)
Achaogen (AKAO) Upgraded to Buy: Here's Why

Achaogen (AKAO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AKAO : 0.11 (unch)
Is the Options Market Predicting a Spike in Achaogen (AKAO) Stock?

Investors need to pay close attention to Achaogen (AKAO) stock based on the movements in the options market lately.

AKAO : 0.11 (unch)
Achaogen: 4Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Achaogen Inc. (AKAO) on Thursday reported a loss of $47.5 million in its fourth quarter.

AKAO : 0.11 (unch)
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019

Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Infection Control Seizes Headlines as Companies Look to Tackle Food-Borne Illnesses

The growing concern over infectious diseases developing in facilities, such as hospitals, has caused a demand for products to combat the spread. These diseases are caused by pathogenic microorganisms such...

AKAO : 0.11 (unch)
CAG : 28.80 (+1.41%)
FLO : 23.04 (+1.36%)
CRMD : 8.14 (-0.73%)
PCTL : 0.0300 (-5.06%)
Achaogen Announces Publication of Plazomicin Phase 3 CARE Study Results in the New England Journal of Medicine

Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Achaogen Announces Closing of $15 Million Underwritten Public Offering

Achaogen, Inc. (Nasdaq:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Principia Biopharma Appoints John W. Smither to Board of Directors

Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology,...

PRNB : 35.09 (-11.81%)
AKAO : 0.11 (unch)
SNNA : 0.79 (unch)
Achaogen Announces Pricing of $15 Million Underwritten Public Offering

Achaogen, Inc. (NASDAQ:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Achaogen Announces Proposed Public Offering of Common Stock

Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield

-- Plazomicin may be well-suited to play a critical role in biodefense preparedness --

AKAO : 0.11 (unch)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ +0.09 , WELL -0.03 , SBAC +0.11 , CCI +0.94 , SO +0.50
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar